EP2997011
Súlfamóýlpýrrólamíðafleiður og notkunin þeirra sem lyfs við að meðhöndla lifrarbólgu B
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.5.2014EP published:
29.8.2018EP application number:
14727752.9
EP translation filed:
21.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
15.5.2034Expiry date:
15.5.2022
Title:
SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
Timeline
Today
16.5.2014EP application
29.8.2018EP Publication
21.11.2018Translation submitted
15.12.2018Registration published
15.5.2022Expires
Owner
Name:
Janssen Sciences Ireland UCAddress:
Eastgate Village, Eastgate, Little Island, County Cork, IE
Inventor
Name:
VANDYCK, KoenAddress:
Paal-Beringen, BE
Name:
HACHÉ, Geerwin, Yvonne, PaulAddress:
Kapellen, BE
Name:
LAST, Stefaan, JulienAddress:
Lint, BE
Name:
MC GOWAN, David, CraigAddress:
Brussel, BE
Name:
ROMBOUTS, GeertAddress:
Borsbeek, BE
Name:
VERSCHUEREN, Wim, GastonAddress:
Berchem (Antwerpen), BE
Name:
RABOISSON, Pierre, Jean-Marie, BernardAddress:
Rosieres, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13168291Date:
17.5.2013Country:
EP
Number:
13175181Date:
4.7.2013Country:
EP
Number:
13182281Date:
29.8.2013Country:
EP
Number:
13191209Date:
31.10.2013Country:
EP
Number:
13198160Date:
18.12.2013Country:
EP
Number:
14157900Date:
5.3.2014Country:
EP
Classification
Categories:
C07D 207/40, A61K 31/401, A61P 31/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.4.2019
Expires: 15.5.2020
Payer: Árnason Faktor
Number: 7
Paid: 7.4.2020
Expires: 15.5.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.4.2021
Expires: 15.5.2022
Payer: Árnason Faktor ehf.